Homepage
Medication Guide
How to Use Pomalidomide
Pomalidomide is a thalidomide analog and belongs to the class of immunomodulators. It is indicated for the treatment of multiple myeloma (MM) and Kaposi's sarcoma (KS). Its use must strictly adher...
503
Friday, October 24th, 2025, 11:52
What Are the Side Effects of Odevixibat (Bylvay)?
Odevixibat (Bylvay) is a selective ileal bile acid transporter (IBAT) inhibitor, indicated for the treatment of pruritus associated with progressive familial intrahepatic cholestasis (PFIC) and Alagil...
503
Friday, October 24th, 2025, 11:28
Precautions for Odevixibat (Bylvay) Administration
Odevixibat (Bylvay) is an ileal bile acid transporter (IBAT) inhibitor. It is indicated for the treatment of progressive familial intrahepatic cholestasis (PFIC)-related pruritus in patients aged 3 mo...
502
Friday, October 24th, 2025, 11:26
How to Use Odevixibat (Bylvay)
Odevixibat (Bylvay) is an ileal bile acid transporter (IBAT) inhibitor used for the treatment of pruritus associated with progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (AL...
502
Friday, October 24th, 2025, 11:00
What Are the Side Effects of Pramipexole?
Pramipexole is a non-ergot dopamine agonist used for the treatment of Parkinson's Disease and moderate-to-severe primary Restless Legs Syndrome (RLS). As a dopamine receptor agonist, while it impr...
501
Friday, October 24th, 2025, 10:43
Precautions for Pramipexole Administration
Pramipexole is a non-ergot dopamine receptor agonist used for the treatment of Parkinson's Disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS). Its efficacy and safety are hig...
502
Friday, October 24th, 2025, 10:38
Indications for Indications for Pramipexole
Pramipexole is a non-ergot dopamine receptor agonist, primarily indicated for the treatment of Parkinson's Disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS).Indications for ...
504
Friday, October 24th, 2025, 10:29
What Are the Side Effects of Eliglustat (Cerdelga)?
Eliglustat (Cerdelga) is a glucosylceramide synthase inhibitor used for the long-term treatment of Type 1 Gaucher Disease in adults, with eliglustat as its active ingredient.What Are the Side Effects ...
502
Friday, October 24th, 2025, 09:27
Precautions for Eliglustat (Cerdelga) Administration
Eliglustat (Cerdelga) is a glucosylceramide synthase inhibitor indicated for the long-term treatment of Type 1 Gaucher Disease (GD1) in adults. Its efficacy and safety are highly dependent on individu...
502
Friday, October 24th, 2025, 09:23
Indications for Eliglustat (Cerdelga)
Eliglustat (Cerdelga) is an oral medication used for the treatment of Type 1 Gaucher Disease (GD1). It alleviates the symptoms of Gaucher Disease by reducing the production of glucosylceramide (GL-1)....
502
Friday, October 24th, 2025, 09:18
8 / 136
1353 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved